Payments Choice Boosts Clinical Trial Participation and Drug Development Outcomes

Sayantan Chakraborty, global co-head of treasury services payments at J.P. Morgan Payments, and Winny Li, group treasurer at pharma firm PPD, part of Thermo Fisher Scientific, tell Karen Webster that payments choice — including real-time and digital transactions — can help speed up reimbursements during critical drug trials, keeping patients happy while the medical field makes new advances in drug development.